Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173054 | SCV000224135 | benign | not specified | 2014-11-19 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000341008 | SCV000458390 | likely benign | Mucopolysaccharidosis type 6 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Center for Pediatric Genomic Medicine, |
RCV000435594 | SCV000511046 | likely benign | not provided | 2016-06-16 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Laboratory of Diagnosis and Therapy of Lysosomal Disorders, |
RCV000341008 | SCV000803136 | benign | Mucopolysaccharidosis type 6 | 2018-01-01 | criteria provided, single submitter | curation | Allele frequency greater than expected for disorder (BS1); Homozygotes reported in GnomAD (BS2); Classified benign by a reputable source (BP6) |
Mendelics | RCV000341008 | SCV001136842 | benign | Mucopolysaccharidosis type 6 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000341008 | SCV001729202 | benign | Mucopolysaccharidosis type 6 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000435594 | SCV001862369 | benign | not provided | 2020-11-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 17458871, 21228398, 22133300) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000173054 | SCV002050840 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000341008 | SCV002797242 | benign | Mucopolysaccharidosis type 6 | 2022-04-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000435594 | SCV004163004 | benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | ARSB: BS1, BS2 |
Breakthrough Genomics, |
RCV000435594 | SCV005224439 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000341008 | SCV002084988 | benign | Mucopolysaccharidosis type 6 | 2019-10-30 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003975252 | SCV004792849 | likely benign | ARSB-related disorder | 2020-03-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |